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Abstract The mediastinum is an anatomically defined
space in which organs and major blood vessels reside with
surrounding soft tissue elements. The thymus is an impor-
tant organ in the mediastinum, and many of the masses
encountered in the mediastinum are related to this organ.
Most neoplasms diagnosed in the mediastinum are epithe-
lial tumours (thymomas and thymic carcinomas), lympho-
mas or germ cell tumours. In contrast, soft tissue tumours
of the mediastinum are rare. In 1963, Pachter and Lattes
systematically reviewed soft tissue pathology of the medi-
astinum, covering the hitherto described [2, 226, 227] In
this review, based on the 2013 WHO classification of soft
tissue tumours and the 2015 WHO classification of tu-
mours of the lung, pleura, thymus and heart, we provide
an updated overview of mesenchymal tumours that may be
encountered in the mediastinum.
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Introduction
Soft tissue tumours arising in the mediastinum are rare. Their
estimated incidence is between 2 and 6 % of mediastinal neo-
plasms [1–3]. However, this often quoted estimate is based on
historical series with relatively small numbers of cases. In addi-
tion, previous reviews of mediastinal soft tissue tumours often
predate novel typing strategies and current classification schemes.
Most soft tissue tumours described elsewhere in the body
have been reported to occur in the mediastinum, of course with
the exception of strictly site- or organ-specific neoplasms such as
GIST. Because of their rarity, most mesenchymal tumours in the
mediastinum have been reported as case reports or small series.
Mediastinal sarcomas may either arise de novo or rarely as “so-
matic-type” malignancy in a mediastinal germ cell tumour
(GCT). Development of a sarcomatous component has been
reported to occur more frequently in mediastinal GCTs than in
other sites [4]. The two most common sarcomas developing in
mediastinal GCTs are rhabdomyosarcoma and angiosarcoma.
In addition, sarcomatous areas as part of a thymic sarcomatoid
carcinoma or pseudosarcomatous stroma in a thymoma may
sometimes be a diagnostic consideration [5–7]. In this review,
we will focus on de novo primary mesenchymal tumours of the
mediastinum. Based on the current WHO classification of soft
tissue tumours [8], we will systematically review those entities
that have been described in the thymus and mediastinum with
an emphasis on their site-specific features.
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Adipocytic tumours
Lipomatous tumours are common in the mediastinum and
may be located in any compartment. All subtypes of
liposarcoma have been reported in the mediastinum.
Lipoma
Lipoma has been frequently reported in the mediastinum and
comprises between 1 and 9 % of primary thymic masses [9,
10]. Mediastinal lipoma may arise from connective tissues
both of the mediastinum and the thymus gland itself.
Thymolipoma
When a circumscribedmediastinal mass lesion is composed of
mature fat and has a distinct component of thymic tissue, it is
considered a site-specific tumour and is termed thymolipoma
[11]. A definite distinction from lipoma that, by definition, is
devoid of thymic tissue may not be possible in small biopsies
[10, 12–14]. The nature of thymolipoma is unclear. Histoge-
netic conceptions postulated that (1) thymolipoma is essential-
ly a lipoma (i.e. an adipocytic neoplasm) with incorporation of
normal thymic tissue and it is (2) a combined neoplasm of
thymic fat and a neoplastic thymic epithelial component, (3)
fatty replacement of a thymoma or (4) fatty replacement of
hyperplastic thymic tissue (i.e. not strictly a neoplasm) [15].
Thymolipoma (Fig. 1) is mainly seen in young adults in the
second to fourth decade but has been described in all ages (range
3–76 years; median 29 years [12, 14, 16, 17]) with several well-
documented paediatric cases [18] and with an equal sex ratio.
Thymolipoma may reach a large size (up to several kilograms)
and is clinically silent in at least one third of cases but may
produce symptoms of breathlessness by compression of lung
tissue, recurrent infection or pain [14]. Asymptomatic tumours
have been known to be present for considerable time, occasion-
ally being confused with cardiomegaly [14, 19–21], although
this misperception is unlikely with modern imaging techniques.
Thymolipoma may be associated with autoimmune symptoms,
such as anaemia, hypogammaglobulinemia, hyperthyroidism
[22] and, most frequently, myasthenia gravis (MG). The inci-
dence ofMG in thymolipoma varies considerable in series, rang-
ing from 0 to 50% [12, 14, 15, 17, 22–24], but is less than 5% in
recent larger series [14, 17, 23]. Patients with thymolipoma-
associated MG tend to be older, and their tumours tend to be
smaller (Fig. 2) [15, 23]. It maywell be thatMG-associated cases
come tomedical attention before these tumours reach a large size
[22]. Surgical resection is curative, andmalignant transformation
does not occur.
Histologically, thymolipomas are encapsulated tumours
composed of mature fat cells and thymic tissue. The latter
consists of epithelial cells and immature TdT-positive lym-
phocytes (“thymocytes”) and may contain Hassall’s corpus-
cles. The proportion of fatty tissue may vary considerably (in
one series from 30 to 80 %) [14, 17]. Rare occurrence of a
thymoma and even thymic carcinoma arising in thymolipoma
has been reported [25, 26].
A number of unusual variants of thymolipoma have been
described, including one with a prominent vascular compo-
nent, designated thymohemangiolipoma [27]. However, fatty
change is a well-known alteration in soft tissue hemangioma
and arterio-venous vascular malformations, and the described
tumour could therefore also be considered a thymic vascular
tumour with lipomatous stroma. Other variants of
thymolipoma contained striated skeletal muscle (“myoid”)
cells, similar to the rare myoid cells which occur in the normal
thymus [28–30]. Two cases of thymolipoma (one in a 9-year-
old girl) with areas of fibrocollagenous tissue were designated
as “fibrothymolipoma” [31].
Lipomatosis
Although lipomatosis is considered a non-neoplastic increase
of normal mature fat, this non-encapsulated mass lesion is
mentioned here for differential diagnostic purposes. In the
mediastinum, it is usually detected by imaging studies, where
it causes widening of the mediastinum. Patients may complain
of dyspnea. It is commonly associated with steroid use,
Cushing’s disease or obesity. Idiopathic cases are very rare
[32–34].
Lipoblastoma
Lipoblastoma (LPB) is a rare adipocytic tumour composed of
fat cells in various stages of maturation, essentially restricted
to the paediatric age group with 90% occurring before 3 years
of age without sex predilection. Mediastinal LPB is very rare
with approximately 30 cases presented in case reports or small
case series [35–66]. Mediastinal LPBmay grow to a large size
and pack a large volume of the thorax, and the precise origin
Fig. 1 Thymolipoma. Thymolipoma in a 43 year-old male, discovered
incidentally during routine physical work-related examination. Mature fat
with thymic tissue with discernable cortical and medullary compartments
and minor cystic change (HE stain)
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of the tumour may be difficult to determine in these cases. A
significant number of mediastinal LPB extend into the neck.
In the series of mediastinal LPB, patients ranged from
6 months to 6.5 years of age (median 19.5 months).
Histologically, LPB is characterized by fatty tissue in varying
degrees of maturation. Most cases are circumscribed, but rarely,
a diffuse growth is seen (diffuse LPB, lipoblastomatosis). Al-
though LPBs are benign tumours, recurrence may occur [35]
and the tumours may envelop vital structures or extend within
orifices such as the spinal canal, hampering complete removal
[43, 51, 58].
Lipoma variants
Angiolipoma, an adipocytic tumour composed of small, often
capillary-sized blood vessels, combined with mature fat cells
has been described in the mediastinum (Fig. 3). As the propor-
tion of fat and blood vessels may vary considerably from case
to case, it is debatable whether some of these cases could also
be considered primary vascular proliferations (capillary heman-
giomas) with an adipose component [67–71].
A few cases of mediastinal spindle cell lipoma with typical
histological features including “ropey” dense collagen strands
and bland spindle cells have been reported [72, 73]. The immu-
nohistochemical profile with CD34 positivity supported the
diagnosis in these cases, but there have been no reports
documenting the presence of 16q or 13q chromosomal aberra-
tions that are characteristic of peripheral spindle cell and pleo-
morphic lipomas [69].
Hibernoma is a rare distinctive benign adipocytic neoplasm
composed of brown fat with microvesicular multivacuolated
lipocytes, usually in a subpleural site [74] or associated with
soft tissue of the chest or extending from the neck [75]. Only
very few cases of hibernoma have been reported as mediastinal
masses [76–79].
Less than ten cases of myelolipoma have been reported in the
mediastinum. Most cases of myelolipoma occurred in adults
(sixth to eighth decade) with no gender predilection and were
often discovered incidentally or at autopsy where death was due
to other causes. Most cases were present in the posterior medi-
astinum, often in a paravertebral location [69, 80–89]. Similar to
in the adrenal gland, the most common site of myelolipoma,
hematopoietic tissue and mature fat are combined in varying
proportions. In patients with hematologic disease, similar masses
can occur as either normal extramedullary hemopoiesis or as
extra-medullary extension of the hematologic tumour itself and
should not be considered myelolipoma [90].
Liposarcoma
Liposarcoma is a malignant adipocytic tumour with various
subtypes which impact on behaviour and prognosis. It is, by
far, the most common primary malignant mesenchymal tu-
mour of the mediastinum. The age range is wide. Paediatric
cases, even occurring in very young infants, have been report-
ed [16, 91–98]. Although an origin from thymic tissue has
been shown in a minority of cases (“thymoliposarcoma”)
[93, 95, 99], cases have also been documented in the posterior
mediastinum [93, 100–102], suggesting a non-thymic origin.
Although numerous case reports and several series [16, 93, 95,
101, 103, 104] of mediastinal liposarcoma have been pub-
lished, most of these predate the current molecular insights
of liposarcoma which may aid in classification. In general,
mediastinal liposarcomas are large, and tumours up to 7 kg
have been reported [105]. Tumoursmay remain asymptomatic
for long periods. Shortness of breath and pain are the most
Fig. 2 Age distribution of thymolipoma with [21, 23, 24] and without [12, 14, 16, 17] myasthenic symptoms
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common symptoms. Despite their large size, vena cava syn-
drome has only rarely been reported [92, 102].
All subtypes of liposarcoma have been reported in the me-
diastinum. Based on their own series and a comprehensive
review of 142 published cases, Boland et al. concluded that
the proportions of liposarcoma subtypes in the mediastinum
differ from those in other sites [106]. In particular, pleomorphic
liposarcoma was considerably more prevalent in the mediasti-
num. In addition, mediastinal liposarcomas, including the pleo-
morphic subtype, frequently contained myxoid areas, a finding
which has been confirmed in other series [93, 101]. Although
the prevalence of mediastinal myxoid liposarcoma was approx-
imately similar to other anatomic locations, a round cell com-
ponent was not identified in the mediastinal tumours. This was
confirmed in other series, in which the presence of a round-cell
component was exceptional [93]. The molecular signatures of
mediastinal liposarcomas correspond to those of liposarcomas
elsewhere, with presence of the t(12;16) FUS-DDIT-3 fusion in
myxoid liposarcoma [107] and amplification ofmdm-2 in well-
differentiated and dedifferentiated liposarcoma [101, 108].
An unusual liposarcoma, termed pleomorphic myxoid
liposarcoma (P-MLPS) by Alaggio et al., appears to have a
predilection for the mediastinum of young patients [103]
(Fig. 4). Five of the 12 cases in their series arose in the medias-
tinum in patients aged from 13 to 20 years of age. Rare adult
cases were described in the series of Boland et al. [106]. In
addition to areas similar to conventional low-grade myxoid
liposarcoma, foci with increased cellularity, hyperchromatic cells
and pleomorphic lipoblasts with increased mitotic activity were
observed in areas with loss of the typical capillary vascular pat-
tern and necrosis. These tumours followed an aggressive course,
with death occurring within 3 years of diagnosis in three of five
patients with available follow-up data. Neither a
t(12;16)(q13;p11), the characteristic genetic hallmark of myxoid
liposarcoma, nor amplification of mdm-2, a marker for well-
differentiated and dedifferentiated liposarcoma, was identified.
Other unusual variants of liposarcoma that have been described
in the mediastinum contained elements of smooth muscle
(lipoleiomyosarcoma) or skeletal muscle [101, 109–111].
The main differential diagnostic considerations of mediasti-
nal liposarcoma are benign lipomatous tumours. Attention to
histological features and the use of molecular markers will lead
to a correct diagnosis. Dedifferentiated liposarcoma may mimic
undifferentiated pleomorphic sarcoma, particularly in biopsy
specimens; demonstration of amplification of mdm-2 confirms
the diagnosis of liposarcoma. So-called fat-forming solitary fi-
brous tumour may enter the differential diagnosis of
liposarcoma. Mdm-2 amplification is absent in these tumours,
and positive staining of STAT-6 on immunohistochemistry may
further support a diagnosis of solitary fibrous tumour (SFT) (see
below). Liposarcoma as a secondary malignancy developing in
a GCT has very rarely been described [112]. Curative surgical
resection is the treatment of choice. The mortality of mediasti-
nal liposarcomas ranges from 30 to 50 %.
Fibroblastic/myofibroblastic tumours
Since many of the tumours in the fibroblastic/myofibroblastic
category have a predilection for the skin and superficial soft
tissues, it is not surprising that only very few of the entities in
this category have been reported in the mediastinum. Desmoid
tumours (aggressive fibromatosis), SFT and inflammatory
myofibroblastic tumour (IMT) are among the more frequently
reported types in the mediastinum.
Aggressive fibromatosis /desmoid tumour
Aggressive fibromatosis is a locally invasive (myo)fibroblastic
proliferation with bland cytology and without metastatic
Fig. 3 Angiolipoma (lipomatous hemangioma). Tumour in the superior
mediastinum in a 67-year-old female who had few complaints but had
persistent pleural effusion. The mass was excised, and no recurrence was
noted after several years of follow-up. a Axial contrast-enhanced CT
image revealing a circumscribed mediastinal mass with variable density.
The mass was found to have been present for several years on
retrospective evaluation of previous examinations. b Mature fat
admixed with thin-walled vessels; there was no atypia of endothelial cells
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potential. About 30 cases of primary mediastinal aggressive
fibromatosis (AF) have been reported as case reports, many of
whichwere included in reviews byNakagiri et al. and Bouchikh
et al. [113, 114] AF in the mediastinum occurs mainly in youn-
ger individuals (age range 3–67 years; median 38 years)
[113–119]. Some cases were associated with surgical scars
[114]. There are no published data about an association with
familial adenomatous polyposis (FAP) or Gardner syndrome. In
contrast to non-mediastinal AF, mediastinal AF cases appear to
occur slightly more frequently in males [120]. Similar to non-
mediastinal AF,mediastinal recurrence is common after surgical
removal, which, in this location, is hampered by anatomical
constraints. Unresectable AF in the mediastinum may be fatal.
Solitary fibrous tumour
SFT is an uncommon but well-known intrathoracic fibroblastic
tumour and often of pleural origin. Since its description, numer-
ous reports of extra-pleural SFTcases have been published with
tumours arising in almost all locations in the body [121].
Mediastinal SFTs without a clear connection with the medias-
tinal pleura have been described in case reports and small series.
Hemangiopericytoma, which has also been described in the
mediastinum, is now considered identical to SFT.
Mediastinal SFT may arise in any compartment of the me-
diastinum. A number of mediastinal SFTs had also contact to
the epicardium [122], and in such cases, it may be questionable
whether these represent true primary mediastinal SFT
[123–125]. Thoracic SFTs reach a large size and may extend
to the chest wall, protrude in the lung or even invade other
structures [124]. SFTs occur over a wide age range but are
typically seen in older adults [126–128]. Paediatric cases are
very rare [129–131]. There is no sex predilection [122–124,
129–169].
The histomorphology of SFT is characterized by a “pattern-
less” architecture with randomly distributed hypocellular and
hypercellular areas, sometimes keloid-like collagen, and thin
“stag-horn” branching capillary vessels that may show
perivascular hyalinization. Tumour cells are generally
spindle shaped with bland cytology and few mitoses.
Fig. 4 Liposarcoma with myxoid change. A posterior mediastinal mass,
surrounding the aorta in a 55-year-old male discovered during routine
health check (a). The mass was excised (b, c). A recurrence was
excised 16 months later; there was no evidence of disease after 1-year
follow-up. a Axial noncontrast CT image at the level of the left atrium
revealing a smoothly marginated retrocardiac mass with variable
attenuation. b Sagittal reformatted CT image showing the retrocardiac
mass to extent from the aortic arch to the diaphragm. c Macroscopic
image of the transected tumour revealing a fleshy, partially thinly
encapsulated mass. d Microscopic image (medium power, HE stain)
showing myxocollagenous stroma with scattered atypical mesenchymal
cells
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Immunohistochemistry is helpful in the diagnosis of SFT and
shows usually strong expression of CD34 [121, 166]. Other
markers typically positive in SFT are CD99 and Bcl2 [127].
Variable staining is seen with smooth muscle actin, while
cytokeratin positivity is very rare [163], except in variants with
epithelioid morphology (see below). Recently, nuclear staining
of STAT6 resulting from NAB2-STAT6 gene fusion [170–172]
has been shown to be a more specific marker for SFT
[173–175], although presence of the NAB2-STAT6 gene fusion
has not yet been formally shown for mediastinal SFT.
It has been suggested that mediastinal SFTs more frequently
show aggressive behaviour compared to non-mediastinal SFTs
[169]. The same criteria predicting malignancy, particularly a
high mitotic count (>4 mitoses per 2 mm2), high cellularity,
pleomorphism and necrosis apply as outside the mediastinum
[127].
So-called fat-forming SFT shows adipocytic differentiation
to such an extent that well-differentiated liposarcoma may enter
the differential diagnosis [132, 143, 151, 176] Although nuclear
STAT6 expression has been shown to be a useful marker for the
diagnosis of fat-forming SFT, particularly in CD34 negative
cases [177] this has also been demonstrated in a significant
proportion of dedifferentiated liposarcomas [108, 178]. How-
ever, staining was limited to the non-lipogenic sarcomatous
areas. In addition, mdm-2 amplification remains a robust mark-
er for liposarcoma and has not been reported in SFT (Fig. 5).
Other variants of SFT include cases with an epithelioid mor-
phology, either as a focal component in combination with “clas-
sical” spindle cells or as tumours that may be exclusively epi-
thelioid [153, 179–185]. This variant may stain for cytokeratin,
which may also be seen in the spindle cells. A mediastinal
epithelioid SFT was reported by Marchevsky et al., who con-
sidered the differential diagnosis of adenomatoid tumour [152].
Epithelioid areas in the highly unusual thymic SFTcase reported
by Tsubochi et al. showed glandular, neuroepithelial and neuro-
endocrine morphology in addition to classical SFT features
[164]. Immunohistochemistry reflected the diverse histology
with STAT6 staining restricted to the classical SFT component.
Mediastinal SFT, in particular malignant cases, may be con-
fused with thymomas with a prominent spindle cell morpholo-
gy (e.g. type A thymoma), mesothelioma, sarcomatoid carcino-
ma, synovial sarcoma and malignant peripheral nerve sheath
tumour (MPNST). In addition to morphological differences,
immunohistochemistrywill help to diagnose SFT inmost cases.
Cytokeratin staining is seen in thymoma, mesothelioma,
sarcomatoid carcinoma and synovial sarcoma and is very rare
in SFT. In addition, STAT6 is a reliable marker for SFTand has
not been described in the other tumours.
Inflammatory myofibroblastic tumour
Inflammatory myofibroblastic tumour (IMT), a tumour com-
posed of (myo)fibroblastic cells and a variably dense non-
neoplastic inflammatory component, has been reported inmany
sites, predominantly in young adults and children [186]. Bona
fide mediastinal IMT is rare with less than 20 convincing cases
reported in the English literature [186–196]. Similar to IMT in
general, which is predominantly a tumour of children and
young adults [186], mediastinal IMT appears to arise mostly
in young adults (range 13–72; median age 34) with a slight
female predominance (M/F=5:8) [187, 188, 190, 192–196].
Histologically, IMT is an infiltrative tumour composed of
(myo)fibroblastic cells admixed with an inflammatory infiltrate
of lymphocytes, plasma cells and eosinophils. Three histological
patterns (granulation tissue-like/compact fascicular spindle cell
pattern with marked inflammation/low cellularity scar-like pat-
tern) that can all occur within a single tumour have been de-
scribed but do not portend a specific biological behaviour [186].
Multifocality is not uncommon in IMT. Cytoplasmic ex-
pression of ALK protein is detectable in about half of cases
and correlates well with presence of ALK gene rearrange-
ments. ALK aberrations have been reported in a single medi-
astinal case [192].
The biological behaviour of IMT is variable and recur-
rences are common, but distant metastasis is rare.
Similar to non-mediastinal sites, treatment rests mainly on
complete local excision. Patients with ALK-rearranged IMTare
potential candidates for treatment with specific inhibitors, al-
though this has so far not been described for mediastinal cases.
Other fibroblastic/myofibroblastic tumours
Calcifying fibrous pseudotumour, a very rare soft tissue tumour
with proposed but unconfirmed relationship to IMT, has been
reported in the mediastinum [197–200]. The tumours all oc-
curred in the mediastinum of adults. No evidence of disease
was recorded during 11–49-month follow-up after surgery in
three patients.
Reports of fibrosarcoma arising in the mediastinum predate
the current concept that adult fibrosarcoma is a very rare tu-
mour. The most recent report of an adult mediastinal fibrosar-
coma dates from 1995 [201]. While in older reports, fibrosar-
coma was one of the more common reported soft tissue tu-
mours, it is likely that these would now be diagnosed as
dedifferentiated liposarcoma, MPNSTor synovial sarcoma. In-
fantile fibrosarcoma has not been reported in the mediastinum.
Three cases of low-grade fibromyxoid sarcoma have been
reported in the mediastinum, among which one case was at-
tached to the epicardium [202–204]. All cases occurred in
middle-aged patients, and one patient had a late recurrence
9 years following surgery, which was resected; metastases were
not recorded.
A single case of infantile myofibromatosis with multifocal
masses in the lung and mediastinal soft tissue in a 4-week-old
male infant has been reported. Five years after surgical resection
and pneumonectomy, no disease activity was recorded [205].
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A single case of mediastinal giant cell angiofibroma was
reported in a 62-year-old female [206]. However, giant cell
angiofibroma, which is most commonly described in the orbit,
is now considered a variant of SFT [207].
Fibrohistiocytic tumours
Fibrohistiocytic tumours are mainly encountered in superficial
soft tissues or joints. Two cases of benign fibrous histiocytoma
in the mediastinum have been reported [208, 209]. Despite its
terminology, angiomatoid fibrous histiocytoma is commonly
included among tumours of uncertain origin and is not consid-
ered a variant of benign fibrous histiocytoma. Two cases of
angiomatoid fibrous histiocytoma have been reported in the
mediastinum [210, 211]. Both tumours were resected without
evidence of recurrence or metastases.
Giant cell tumour of soft tissue (GCT) is most commonly
observed in superficial soft tissue of the extremities, trunk and
head and neck. Five primary mediastinal cases have been re-
ported, occurring in individuals aged 18–53 years (in three
female and two male patients) [212–214]. The tumours were
almost all located in the posterior mediastinum and ranged from
2.5 to 15 cm, filling the hemithorax. No recurrences were noted,
but the follow-up period was not stated in all published cases.
Malignant fibrohistiocytic tumours, previously referred to as
malignant fibrous histiocytoma (MFH), are now classified as
undifferentiated high-grade pleomorphic sarcomas and are not
considered of true histiocytic lineage (see part 2 of this review).
So-called MFH cases have been recorded in the mediastinum
with generally poor prognosis.
Secondary mediastinal mesenchymal tumours
in germ cell tumours
When amediastinal sarcoma is diagnosed, the possibility must
be considered that sarcomatous tissue remains as the sole
component in a long-standing primary mediastinal GCT, par-
ticularly in younger male patients [215]. Likewise, a medias-
tinal sarcoma could be the metastatic vestige of a burnt-out
primary gonadal GCT. Demonstration of a germ cell (GC)
origin of a mediastinal sarcoma may be accomplished by thor-
ough sampling to reveal GCT remnants. Serological
Fig. 5 Fat-forming solitary fibrous tumour. A large tumour in the chest
cavity in a 23-year-old female who complained of shortness of breath.
The mass was excised but later recurred and resulted in death of the
patient. a CT image showing a large tumour that occupies the anterior
and posterior mediastinum. bHE stain showingmature fat tissue admixed
with ill-defined nodules of spindle cells with elongated nuclei and
tapering cytoplasm. c CD34 stain which is diffusely positive in the
spindle cells. d STAT-6 immunohistochemistry with diffuse nuclear and
cytoplasmic positivity
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investigations (β-HCG, AFP) may reveal a cryptic GCT. The
presence of isochromosome 12p (i(12p)) is a characteristic
abnormality of type II GCTs [216, 217] which persists in the
somatic elements when the typical GCT components are no
longer recognizable [218–220]. Thus, identifying an i12p in
the mesenchymal tissue could confirm the origin of a medias-
tinal sarcoma from a GCT. Development of a sarcomatous
component in a GCT occurs more frequently in mediastinal
GCTs than in other sites [4]. It has been suggested that this
results from the fact that GCTs in this location grow undetect-
ed over longer time periods, are larger and may acquire ma-
lignant somatic tumour subclones more frequently [215]. The
two most common sarcomas developing in mediastinal GCTs
are rhabdomyosarcoma and angiosarcoma [4, 215, 221, 222].
Less commonly reported sarcomas arising in GCTs are
leiomyosarcoma, MPNST and, rarely, liposarcoma [4, 215,
222, 223]. Although most secondary sarcomas in GCTs de-
velop in the anterior mediastinum, rare cases arise in the pos-
terior mediastinum. Similarly and in analogy to somatic
(teratomatous) elements becoming the dominant tissue in
GCTs treated by chemotherapy, sarcomatous tissue may be
the only residual tissue left after chemotherapeutically treated
GCTs [224, 225]. Treatment should be tailored to the somatic
component rather than to its germ cell origin [223]. Neverthe-
less, similar to non-germ-cell-related sarcoma, the prognosis
of a mediastinal sarcoma arising in a GCT is poor.
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